<SEC-DOCUMENT>0001062822-21-000003.txt : 20210114
<SEC-HEADER>0001062822-21-000003.hdr.sgml : 20210114
<ACCEPTANCE-DATETIME>20210114081310
ACCESSION NUMBER:		0001062822-21-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210114
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210114
DATE AS OF CHANGE:		20210114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXICON PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001062822
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				760474169
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30111
		FILM NUMBER:		21527533

	BUSINESS ADDRESS:	
		STREET 1:		8800 TECHNOLOGY FOREST PLACE
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381
		BUSINESS PHONE:		2818633000

	MAIL ADDRESS:	
		STREET 1:		8800 TECHNOLOGY FOREST PLACE
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON PHARMACEUTICALS, INC./DE
		DATE OF NAME CHANGE:	20070426

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON GENETICS INC/TX
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrx-20210114.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:9a524c9d-bdb7-4a14-83b7-3237db6881e8,g:24279acb-8a72-48fc-a96f-dfe7b42cdc3a,d:ff544c08136647bb89497e2d44283fc0--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lxrx-20210114</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF80L2ZyYWc6MTU0MjBkMTU5OThlNDEwZTk1Mjc4Y2M4ZDA0NjBkYjUvdGFibGU6OGE3NjdiNDI5Zjk4NGUzMTlkNWNmMzQ2ZmIxNWMyODAvdGFibGVyYW5nZTo4YTc2N2I0MjlmOTg0ZTMxOWQ1Y2YzNDZmYjE1YzI4MF8wLTEtMS0xLTA_bfc6413e-3a14-4dfa-877d-eb65ca21a5e5">0001062822</ix:nonNumeric><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF80L2ZyYWc6MTU0MjBkMTU5OThlNDEwZTk1Mjc4Y2M4ZDA0NjBkYjUvdGFibGU6OGE3NjdiNDI5Zjk4NGUzMTlkNWNmMzQ2ZmIxNWMyODAvdGFibGVyYW5nZTo4YTc2N2I0MjlmOTg0ZTMxOWQ1Y2YzNDZmYjE1YzI4MF8xLTEtMS0xLTA_0d7062ab-e29e-4229-89fb-fc2f0a3e4274">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lxrx-20210114.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001062822</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-14</xbrli:startDate><xbrli:endDate>2021-01-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iff544c08136647bb89497e2d44283fc0_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjkw_eda48d50-8406-42ed-94e3-50db073c33f3">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18yNjY_d52817f0-9e4d-43b4-bc33-119be6a896a0">January 14, 2021</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg2_a927da01-9528-4837-9921-4aa6ccbe0abb">Lexicon Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:32.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6ZTg3MmVkZmFhMTlkNDgwNWI4YmQ1NjIwOThjOTM5N2IvdGFibGVyYW5nZTplODcyZWRmYWExOWQ0ODA1YjhiZDU2MjA5OGM5Mzk3Yl8wLTAtMS0xLTA_5136fe78-018d-43f3-8fc2-eaa30815f61b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6ZTg3MmVkZmFhMTlkNDgwNWI4YmQ1NjIwOThjOTM5N2IvdGFibGVyYW5nZTplODcyZWRmYWExOWQ0ODA1YjhiZDU2MjA5OGM5Mzk3Yl8wLTEtMS0xLTA_354c7644-1924-49af-bca6-b744eb62ba5d">000-30111</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6ZTg3MmVkZmFhMTlkNDgwNWI4YmQ1NjIwOThjOTM5N2IvdGFibGVyYW5nZTplODcyZWRmYWExOWQ0ODA1YjhiZDU2MjA5OGM5Mzk3Yl8wLTItMS0xLTA_b7566d72-85b7-4f32-9300-8d7cf1b3881e">76-0474169</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg3_883ab13a-13c6-4f0c-80bd-adc816153321">8800 Technology Forest Place</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg4_89091cf2-aef2-4b25-bc07-3d94d1cc6a76">The Woodlands</ix:nonNumeric>, <ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjgw_769fc4cd-f9d5-4b2d-b906-dbb0ac78e8d6">Texas</ix:nonNumeric> <ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM180MDk_b5b82a78-b476-47ee-80f8-bb0e064ba580">77381</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices and Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM180Njg_99a4c6fc-729c-4290-b91b-28e52bd034d0">281</ix:nonNumeric>) <ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjkx_02c7e675-a481-4b2a-898c-e2cbb30e3ab2">863-3000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.421%"><tr><td style="width:1.0%"></td><td style="width:34.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6NmNmMzBhZjFhMGEwNDExMjk2ODM1YmI4ZDZmOWFlMzUvdGFibGVyYW5nZTo2Y2YzMGFmMWEwYTA0MTEyOTY4MzViYjhkNmY5YWUzNV8xLTAtMS0xLTA_1d4c6642-811a-4baf-8e8e-22d8d1ade720">Common Stock, par value $0.001</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6NmNmMzBhZjFhMGEwNDExMjk2ODM1YmI4ZDZmOWFlMzUvdGFibGVyYW5nZTo2Y2YzMGFmMWEwYTA0MTEyOTY4MzViYjhkNmY5YWUzNV8xLTEtMS0xLTA_fea3ec2e-b576-484f-8b08-c95437cb55e6">LXRX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6NmNmMzBhZjFhMGEwNDExMjk2ODM1YmI4ZDZmOWFlMzUvdGFibGVyYW5nZTo2Y2YzMGFmMWEwYTA0MTEyOTY4MzViYjhkNmY5YWUzNV8xLTItMS0xLTA_6382938d-2c41-4de5-8f41-1bb4dc011c40">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjkz_d3c840d8-dc7c-4621-9d0c-4d3ebbb7b8c0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjgx_001193b1-81b5-4f0f-8fa8-722be0690031">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17&#160;CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjgz_961b7748-cb0f-4263-b065-3512468ec402">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR 240.14d-2(b))</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg0_755364df-ba4e-43a2-9d7a-5e5b149a1bd7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg1_e12e1e8f-9208-4a4a-afd4-8f18c0611f85">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iff544c08136647bb89497e2d44283fc0_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 8.01 &#160;&#160;&#160;&#160;Other Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On January 14, 2021, we issued a press release providing a regulatory update on sotagliflozin in heart failure.  The full text of the press release issued in connection with the announcement is attached hereto as Exhibit 99.1 and incorporated herein by this reference.</span></div><div><span><br/></span></div><div id="iff544c08136647bb89497e2d44283fc0_10"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="regulatoryupdateonsotaglif.htm">Press Release of Lexicon Pharmaceuticals, Inc. dated January 14, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EX-104</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iff544c08136647bb89497e2d44283fc0_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signatures</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:52.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lexicon Pharmaceuticals, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:   January 14, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/ Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Brian T. Crum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Vice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">President and General Counsel</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>lxrx-20210114.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9a524c9d-bdb7-4a14-83b7-3237db6881e8,g:24279acb-8a72-48fc-a96f-dfe7b42cdc3a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lxrx="http://www.lexpharma.com/20210114" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lexpharma.com/20210114">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20210114_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20210114_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20210114_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20210114_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.lexpharma.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>3
<FILENAME>lxrx-20210114_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9a524c9d-bdb7-4a14-83b7-3237db6881e8,g:24279acb-8a72-48fc-a96f-dfe7b42cdc3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20210114.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.lexpharma.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>lxrx-20210114_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9a524c9d-bdb7-4a14-83b7-3237db6881e8,g:24279acb-8a72-48fc-a96f-dfe7b42cdc3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20210114.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.lexpharma.com/role/Cover" xlink:type="extended" id="i60b77a33bfd747a3b911e2940d683992_Cover"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lxrx-20210114_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9a524c9d-bdb7-4a14-83b7-3237db6881e8,g:24279acb-8a72-48fc-a96f-dfe7b42cdc3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_5eecfcce-7cbf-4ed7-8b39-bb5683320ffe_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_e0a504b2-e324-427e-8a08-1f0e8bc585e0_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c677bf2d-0cf7-439b-8bed-6fab2644c2ab_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6b5cdbb3-05d2-4975-a6e5-c34eade8d312_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_22dd8543-3398-42f9-96cd-8dc16213f068_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bf5fe88f-a6c9-42ee-8992-b722246fc3b4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_706c1271-82d5-4741-91c9-61c8406aca49_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6b631f80-f568-4229-bd00-ca9596a74620_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_555939dd-78b1-4c22-b490-fafef18635f1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f9849f15-1a91-4381-95ee-bca03b4aacd8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_050fdf79-c212-49fb-9e30-d372b0d8996d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8d6ad2ca-c286-448c-b57b-0278b1bef247_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c3996d5a-4018-4416-adda-e4a67b2df477_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2f57fd22-ed64-4a63-bff1-7ba77a03bdab_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5cf22589-a838-4868-a29a-2cf091e713f0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f605402b-4558-4683-8612-a9c710db0ec6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_260bfc97-f6eb-495f-837f-92f556d8c204_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7214b9ed-6c3b-42de-bb18-5193b24e5cb1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_863259b8-2349-4290-a5a9-69aeeefbe327_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_859a1ada-7f32-4869-832f-adeffcc05810_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_fcb5f9de-27c2-48f7-9888-5b6edd065586_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_68ff884e-bd88-41cd-aa24-5b527bc87f96_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lxrx-20210114_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9a524c9d-bdb7-4a14-83b7-3237db6881e8,g:24279acb-8a72-48fc-a96f-dfe7b42cdc3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20210114.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.lexpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_64fcee98-7b3d-4b77-9be8-baea900988f0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_DocumentType_64fcee98-7b3d-4b77-9be8-baea900988f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_729433b3-bdf9-4ecc-9cc5-14695a891f91" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_DocumentPeriodEndDate_729433b3-bdf9-4ecc-9cc5-14695a891f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_94367d50-6554-447e-a10b-b2d40ab0d348" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityRegistrantName_94367d50-6554-447e-a10b-b2d40ab0d348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b179181e-39c3-4098-b479-b00ec440dab2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b179181e-39c3-4098-b479-b00ec440dab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_60c13abd-4fdc-4c82-b327-c5f675645ca7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityFileNumber_60c13abd-4fdc-4c82-b327-c5f675645ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1e71c424-08d7-4a8c-925c-54daea219637" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityTaxIdentificationNumber_1e71c424-08d7-4a8c-925c-54daea219637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1d5f28ec-87f2-44b8-b85e-6b38efde96a6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityAddressAddressLine1_1d5f28ec-87f2-44b8-b85e-6b38efde96a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1a76b93a-cd91-48ad-92ed-ae39fdfa376e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityAddressCityOrTown_1a76b93a-cd91-48ad-92ed-ae39fdfa376e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_68cf5acd-96a6-42dd-93b8-e1f25a2a37db" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityAddressStateOrProvince_68cf5acd-96a6-42dd-93b8-e1f25a2a37db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aaeff403-2178-4202-b7cb-be42644652dc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityAddressPostalZipCode_aaeff403-2178-4202-b7cb-be42644652dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3ff5ffb7-d92c-4c48-a836-d285db350223" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_CityAreaCode_3ff5ffb7-d92c-4c48-a836-d285db350223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cc77f2d2-b78d-4668-98c3-4ee9c9b641b8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_LocalPhoneNumber_cc77f2d2-b78d-4668-98c3-4ee9c9b641b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1e71d324-4dd8-4fdd-9ccf-cf1c43594bc1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_Security12bTitle_1e71d324-4dd8-4fdd-9ccf-cf1c43594bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e4b1d235-4f05-4e3e-aa78-5f0ced53127c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_TradingSymbol_e4b1d235-4f05-4e3e-aa78-5f0ced53127c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3a40a1b3-a060-4a9d-9b60-c5e9eb7b2543" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_SecurityExchangeName_3a40a1b3-a060-4a9d-9b60-c5e9eb7b2543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_df1187e4-1783-4e29-aa8c-a78ce59220f5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_WrittenCommunications_df1187e4-1783-4e29-aa8c-a78ce59220f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_5768ad4e-2ab3-4857-b4da-74117646c1c4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_SolicitingMaterial_5768ad4e-2ab3-4857-b4da-74117646c1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_dbdbfc9c-3873-4aa5-9808-90abc46e8a54" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_PreCommencementTenderOffer_dbdbfc9c-3873-4aa5-9808-90abc46e8a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_bdf20da1-8d9e-4cc0-a4b9-108368deab2f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_bdf20da1-8d9e-4cc0-a4b9-108368deab2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_97f21a5b-eb75-40e2-a630-52a1d67443de" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityEmergingGrowthCompany_97f21a5b-eb75-40e2-a630-52a1d67443de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1d51576d-3bc6-45e2-8a6e-c8040b16b28c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_EntityCentralIndexKey_1d51576d-3bc6-45e2-8a6e-c8040b16b28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_120c5dcf-fd20-4585-938c-16a1238add93" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8acef3f6-9126-4fab-a2e8-116d968b5f1b" xlink:to="loc_dei_AmendmentFlag_120c5dcf-fd20-4585-938c-16a1238add93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>regulatoryupdateonsotaglif.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if43c515b5c0a4854a49b2ecd2e90fba1_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">LEXICON PHARMACEUTICALS PROVIDES REGULATORY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">UPDATE ON SOTAGLIFLOZIN IN HEART FAILURE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">The Woodlands, Texas, January 14, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#8211; Lexicon Pharmaceuticals, Inc. (Nasdaq&#58; LXRX) </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">announced today that it has received U.S. Food and Drug Administration (FDA) regulatory feedback that the results of its SOLOIST and SCORED Phase 3 clinical studies can support a new drug application (NDA) submission for an indication to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent visits for heart failure in adult patients with type 2 diabetes with either worsening heart failure or additional risk factors for heart failure.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The feedback was provided in response to a request made by Lexicon following the completion of the SOLOIST and SCORED studies relating to the potential submission of an NDA based on the results of such studies, taking into account their early close-out and other considerations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This regulatory feedback clears a key hurdle for partnership discussions around sotagliflozin in heart failure and enables a potential NDA filing in 2021.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Lonnel Coats, Lexicon&#8217;s president and chief executive officer, will present at the 39</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Annual J.P. Morgan Healthcare Conference today at 2&#58;50 p.m. ET.  A webcast of the event will be available in the &#8220;Events&#8221; section of the Lexicon website at www.lexpharma.com.  </font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">About the SOLOIST and SCORED Studies</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SOLOIST was a multi-center, randomized, double-blinded, placebo-controlled Phase 3 study evaluating the cardiovascular efficacy of sotagliflozin versus placebo when added to standard of care in 1,222 patients with type 2 diabetes who had recently been hospitalized for worsening heart failure. The primary endpoint was the total number of events comprised of deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure in patients treated with sotagliflozin compared with placebo. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SCORED was a multi-center, randomized, double-blinded, placebo-controlled Phase 3 study evaluating the cardiovascular efficacy of sotagliflozin versus placebo when added to standard of care in 10,584 patients with type 2 diabetes, chronic kidney disease with eGFR of 25 to 60 ml per minute per 1.73 m</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> of body-surface area, and risks for cardiovascular disease. The primary endpoint was the total number of events comprised of deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure in patients treated with sotagliflozin compared with placebo. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Both SOLOIST and SCORED achieved their respective primary endpoints.  Results from both studies were presented at the Late-Breaking Science Session of the American Heart Association (AHA) Scientific Sessions 2020 and simultaneously published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">The New England Journal of Medicine (NEJM)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> in two separate articles titled&#58; &#8220;Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure&#8221; and &#8220;Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">About Sotagliflozin</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Discovered using Lexicon&#8217;s unique approach to gene science, sotagliflozin is an oral dual inhibitor of two proteins responsible for glucose regulation known as sodium-glucose co-transporter types 1 and 2 (SGLT1 and SGLT2). SGLT1 is responsible for glucose absorption in the gastrointestinal tract, and SGLT2 is responsible for glucose reabsorption by the kidney. Sotagliflozin is approved in the European Union (EU) for use as an adjunct to insulin therapy to improve blood sugar (glycemic) control in adults with type 1 diabetes with a body mass index &#8805; 27 kg&#47;m</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, who could not achieve adequate glycemic control despite optimal insulin therapy, but has not yet been commercially launched.</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">About Lexicon Pharmaceuticals</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients&#8217; lives. Through its Genome5000&#8482; program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon advanced one of these medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in neuropathic pain, heart failure, diabetes and metabolism and other indications.  For additional information, please visit www.lexpharma.com.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Safe Harbor Statement</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">This press release contains &#8220;forward-looking statements,&#8221; including statements relating to Lexicon&#8217;s clinical development of and regulatory filings for sotagliflozin, partnership discussions relating to sotagliflozin and the potential therapeutic and commercial potential of sotagliflozin, as well as Lexicon&#8217;s financial position and long-term outlook on its business, including the clinical development of, regulatory filings for, and potential therapeutic and commercial potential of its other drug candidates. In addition, this press release also contains forward looking statements relating to Lexicon&#8217;s growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management&#8217;s current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including Lexicon&#8217;s ability to meet its capital requirements, successfully conduct preclinical and clinical development and obtain necessary regulatory approvals of LX9211, sotagliflozin and its other potential drug candidates on its anticipated timelines, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates. Any of these risks, uncertainties and other factors may cause Lexicon&#8217;s actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under &#8220;Risk Factors&#8221; in Lexicon&#8217;s annual report on Form 10-K for the year ended December 31, 2019, as filed with the Securities </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For Inquiries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chas Schultz</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive Director, Corporate Communications and Investor Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Lexicon Pharmaceuticals</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(281) 863-3421</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">cschultz&#64;lexpharma.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>lxrx-20210114_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrx-20210114.xsd" xlink:type="simple"/>
    <context id="i1ac135dea5db41afba5220b46988a960_D20210114-20210114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001062822</identifier>
        </entity>
        <period>
            <startDate>2021-01-14</startDate>
            <endDate>2021-01-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF80L2ZyYWc6MTU0MjBkMTU5OThlNDEwZTk1Mjc4Y2M4ZDA0NjBkYjUvdGFibGU6OGE3NjdiNDI5Zjk4NGUzMTlkNWNmMzQ2ZmIxNWMyODAvdGFibGVyYW5nZTo4YTc2N2I0MjlmOTg0ZTMxOWQ1Y2YzNDZmYjE1YzI4MF8wLTEtMS0xLTA_bfc6413e-3a14-4dfa-877d-eb65ca21a5e5">0001062822</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF80L2ZyYWc6MTU0MjBkMTU5OThlNDEwZTk1Mjc4Y2M4ZDA0NjBkYjUvdGFibGU6OGE3NjdiNDI5Zjk4NGUzMTlkNWNmMzQ2ZmIxNWMyODAvdGFibGVyYW5nZTo4YTc2N2I0MjlmOTg0ZTMxOWQ1Y2YzNDZmYjE1YzI4MF8xLTEtMS0xLTA_0d7062ab-e29e-4229-89fb-fc2f0a3e4274">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjkw_eda48d50-8406-42ed-94e3-50db073c33f3">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18yNjY_d52817f0-9e4d-43b4-bc33-119be6a896a0">2021-01-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg2_a927da01-9528-4837-9921-4aa6ccbe0abb">Lexicon Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6ZTg3MmVkZmFhMTlkNDgwNWI4YmQ1NjIwOThjOTM5N2IvdGFibGVyYW5nZTplODcyZWRmYWExOWQ0ODA1YjhiZDU2MjA5OGM5Mzk3Yl8wLTAtMS0xLTA_5136fe78-018d-43f3-8fc2-eaa30815f61b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6ZTg3MmVkZmFhMTlkNDgwNWI4YmQ1NjIwOThjOTM5N2IvdGFibGVyYW5nZTplODcyZWRmYWExOWQ0ODA1YjhiZDU2MjA5OGM5Mzk3Yl8wLTEtMS0xLTA_354c7644-1924-49af-bca6-b744eb62ba5d">000-30111</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6ZTg3MmVkZmFhMTlkNDgwNWI4YmQ1NjIwOThjOTM5N2IvdGFibGVyYW5nZTplODcyZWRmYWExOWQ0ODA1YjhiZDU2MjA5OGM5Mzk3Yl8wLTItMS0xLTA_b7566d72-85b7-4f32-9300-8d7cf1b3881e">76-0474169</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg3_883ab13a-13c6-4f0c-80bd-adc816153321">8800 Technology Forest Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg4_89091cf2-aef2-4b25-bc07-3d94d1cc6a76">The Woodlands</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjgw_769fc4cd-f9d5-4b2d-b906-dbb0ac78e8d6">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM180MDk_b5b82a78-b476-47ee-80f8-bb0e064ba580">77381</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM180Njg_99a4c6fc-729c-4290-b91b-28e52bd034d0">281</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjkx_02c7e675-a481-4b2a-898c-e2cbb30e3ab2">863-3000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6NmNmMzBhZjFhMGEwNDExMjk2ODM1YmI4ZDZmOWFlMzUvdGFibGVyYW5nZTo2Y2YzMGFmMWEwYTA0MTEyOTY4MzViYjhkNmY5YWUzNV8xLTAtMS0xLTA_1d4c6642-811a-4baf-8e8e-22d8d1ade720">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6NmNmMzBhZjFhMGEwNDExMjk2ODM1YmI4ZDZmOWFlMzUvdGFibGVyYW5nZTo2Y2YzMGFmMWEwYTA0MTEyOTY4MzViYjhkNmY5YWUzNV8xLTEtMS0xLTA_fea3ec2e-b576-484f-8b08-c95437cb55e6">LXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGFibGU6NmNmMzBhZjFhMGEwNDExMjk2ODM1YmI4ZDZmOWFlMzUvdGFibGVyYW5nZTo2Y2YzMGFmMWEwYTA0MTEyOTY4MzViYjhkNmY5YWUzNV8xLTItMS0xLTA_6382938d-2c41-4de5-8f41-1bb4dc011c40">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjkz_d3c840d8-dc7c-4621-9d0c-4d3ebbb7b8c0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjgx_001193b1-81b5-4f0f-8fa8-722be0690031">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjgz_961b7748-cb0f-4263-b065-3512468ec402">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg0_755364df-ba4e-43a2-9d7a-5e5b149a1bd7">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="i1ac135dea5db41afba5220b46988a960_D20210114-20210114"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmNTQ0YzA4MTM2NjQ3YmI4OTQ5N2UyZDQ0MjgzZmMwL3NlYzpmZjU0NGMwODEzNjY0N2JiODk0OTdlMmQ0NDI4M2ZjMF8xL2ZyYWc6NGQ2NzkwNzc5NDM5NDQxNzgxOTg1MTFkMmM4NDZiZTMvdGV4dHJlZ2lvbjo0ZDY3OTA3Nzk0Mzk0NDE3ODE5ODUxMWQyYzg0NmJlM18xNjg1_e12e1e8f-9208-4a4a-afd4-8f18c0611f85">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140505817737976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 14,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Lexicon Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0474169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8800 Technology Forest Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">The Woodlands<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">863-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LXRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001062822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/;
M@L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V
M&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G60VY6= ;N
M\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG
M5LJ]AU>RY1AQ_)[E#U!+ P04    " "D02Y2)!Z;HJT   #X 0  &@   'AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K
M+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;
MM(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /
M,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G
M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ I$$N4F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( *1!+E(YV6F8[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( *1!+E*97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ I$$N4GKWWE@T!   /1   !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( *1!+E*#J:4#U $
M #(&   -              "  7@,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  .\2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lxrx-20210114.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lexpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lxrx-20210114.htm">lxrx-20210114.htm</File>
    <File>lxrx-20210114.xsd</File>
    <File>lxrx-20210114_cal.xml</File>
    <File>lxrx-20210114_def.xml</File>
    <File>lxrx-20210114_lab.xml</File>
    <File>lxrx-20210114_pre.xml</File>
    <File>regulatoryupdateonsotaglif.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lxrx-20210114.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "lxrx-20210114_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lxrx-20210114_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lxrx-20210114.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lxrx-20210114_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrx-20210114_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lxrx-20210114.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lxrx",
   "nsuri": "http://www.lexpharma.com/20210114",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20210114.htm",
      "contextRef": "i1ac135dea5db41afba5220b46988a960_D20210114-20210114",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.lexpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20210114.htm",
      "contextRef": "i1ac135dea5db41afba5220b46988a960_D20210114-20210114",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001062822-21-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062822-21-000003-xbrl.zip
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M[]U=;[D=N*^V![7;43?8-4EXD_<+??3FV?J3=/E2[S?/_@]02P,$%     @
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M=[LXZ.Y\AK..D!*$L]NU^>[D^IFU&%BA'SG&NI]#*NKPM@J_8.1=YMQ((9S
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MRPIFC-+U@=%A#$RX@_ER"4=;^S>+)^*=X8FCO;L?NH_NU?RCO?\!4$L#!!0
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M7YNN+%!'(D_"MX)'4FT9/'&U-@X'\W?\>"CQXU=4;+>E>DGHF!H[H=:CVI5
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M+0'@QIWCV<6G+F-FHKT\I%\,6^Q_LV2^L&BUX=H@>#A1:4J_5^4: ,2:BD#
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M   1              "  0    !L>')X+3(P,C$P,3$T+FAT;5!+ 0(4 Q0
M   ( *1!+E+HS%FSA@(  'H)   1              "  2D3  !L>')X+3(P
M,C$P,3$T+GAS9%!+ 0(4 Q0    ( *1!+E)>;RKY@@$  ,@"   5
M      "  =X5  !L>')X+3(P,C$P,3$T7V-A;"YX;6Q02P$"% ,4    " "D
M02Y2_ZI/)@8"  !M!@  %0              @ &3%P  ;'AR>"TR,#(Q,#$Q
M-%]D968N>&UL4$L! A0#%     @ I$$N4J_JWJE:"@  HET  !4
M     ( !S!D  &QX<G@M,C R,3 Q,31?;&%B+GAM;%!+ 0(4 Q0    ( *1!
M+E(EQ"S@K 8  &@Q   5              "  5DD  !L>')X+3(P,C$P,3$T
M7W!R92YX;6Q02P$"% ,4    " "D02Y22.V&=< -  !/.0  '@
M    @ $X*P  <F5G=6QA=&]R>75P9&%T96]N<V]T86=L:68N:'1M4$L%!@
0   '  < U@$  #0Y      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
